In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Chemical and pharmaceutical bulletin

• Publication date

  1988-07-25

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1248/CPB.36.2576PMID 3149211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.

  1988cited by this paper
• A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.

  1988cited by this paper
• Endocrine and clinical effects of leuprolide in prostatic cancer

  1984cited by this paper
• Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

  1984cited by this paper
• Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.

  1982cited by this paper
• Long‐term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders

  1980cited by this paper
• Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios.

  1977cited by this paper
• Lactic/glycolic acid polymers as narcotic antagonist delivery systems.

  1975cited by this paper

• Preparation of Poly(Lactic Acid) / Hydroxyapatite Core-Shell Nanoparticles Using Different Solvents for Drug Delivery Carriers

  2024cites this paper
• Patient-Centric Long-Acting Injectable and Implantable Platforms—An Industrial Perspective

  2024cites this paper
• The industrial design, translation, and development strategies for long-acting peptide delivery

  2022cites this paper
• Development of beta-carotene-loaded poly(lactic acid)/hydroxyapatite core-shell nanoparticles for osteoblast differentiation

  2022cites this paper
• Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic

  2022influential citation
• Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules

  2022cites this paper
• An overview of the production methods for core-shell microspheres for parenteral controlled drug delivery.

  2021cites this paper
• Evaluation of Drug-Loading Ability of Poly(Lactic Acid)/Hydroxyapatite Core–Shell Particles

  2021cites this paper
• Role of hydrolytic degradation of polylactide drug carriers in developing micro- and nanoscale polylactide-based drug dosage forms

  2020cites this paper
• Self-healing of ‘green’ thermoset zein resins with irregular shaped waxy maize starch-based/poly(D,L-lactic-co-glycolic acid) microcapsules

  2019cites this paper
• Abu-Awwad, Hosam Al-Deen M. and Thiagarajan, Lalitha and Dixon, James E. (2017) Controlled release of GAG-binding enhanced transduction (GET) peptides

  2018influential citation
• Reverse Engineering the 1-Month Lupron Depot®

  2018cites this paper
• Controlled release of GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery.

  2017influential citation
• Comparative in vitro release and clinical pharmacokinetics of leuprolide from Luphere 3M Depot, a 3-month release formulation of leuprolide acetate

  2017cites this paper
• One-step synthesis, biodegradation and biocompatibility of polyesters based on the metabolic synthon, dihydroxyacetone.

  2016cites this paper
• Tissue Reaction to a Novel Bone Substitute Material Fabricated With Biodegradable Polymer-Calcium Phosphate Nanoparticle Composite

  2016cites this paper
• Injectable formulations of poly(lactic acid) and its copolymers in clinical use.

  2016cites this paper
• Preparation and Evaluation of Methoxypolyethylene Glycol-Poly (DL-Lactic Acid) Nanoparticles Loaded with Glycyrrhetic Acid

  2016cites this paper
• Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.

  2016cites this paper
• Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics.

  2015cites this paper
• Single-injection vaccines: Progress, challenges, and opportunities.

  2015cites this paper
• Double emulsion solvent evaporation techniques used for drug encapsulation.

  2015cites this paper
• Preparation of submicron particles for theranostic applications : imaging and therapy

  2015cites this paper
• Challenges and opportunities in polymer technology applied to veterinary medicine.

  2014cites this paper
• Sustained release of estrogens from PEGylated nanoparticles for treatment of secondary spinal cord injury

  2013cites this paper
• Pentablock copolymer based controlled release formulations of small and macromolecules for ophthalmic applications

  2012cites this paper
• Biodegradable Polymeric Assemblies for Biomedical Materials

  2011cites this paper
• Preparation of ONO‐1301‐loaded poly(lactide‐co‐glycolide) microspheres and their effect on nerve conduction velocity

  2011cites this paper
• Poly(lactic-co-glycolic acid) nanoparticles as candidate DNA vaccine carrier for oral immunization of Japanese flounder (Paralichthys olivaceus) against lymphocystis disease virus.

  2011cites this paper
• [Preparation of PLGA microspheres encapsulating highly concentrated glycyrrhizin and the bile elimination of glycyrrhizin after subcutaneous administration in rats].

  2010cites this paper
• Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo.

  2010cites this paper
• Solid Lipid Nanoparticles as Drug Delivery System for Water-Insoluble Drugs

  2010cites this paper
• Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.

  2009cites this paper
• Hormonal therapy in prostate cancer

  2009cites this paper
• Engineered polymers for advanced drug delivery.

  2009cites this paper
• Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug.

  2009cites this paper
• Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic

  2008cites this paper
• Biodegradable polymeric materials

  2008cites this paper
• Particle Characteristics and Biodistribution of Camptothecin-Loaded PLA/(PEG-PPG-PEG) Nanoparticles

  2008cites this paper
• In Vitro and In Vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs

  2008cites this paper
• Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic.

  2008cites this paper
• Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.

  2008cites this paper
• Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).

  2008cites this paper
• Drug delivery from ocular implants

  2006cites this paper
• Degradation of Biodegradable Aliphatic Polyesters

  2006cites this paper
• G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.

  2006cites this paper
• Application of TPGS in polymeric nanoparticulate drug delivery system.

  2006cites this paper
• Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer

  2006cites this paper
• Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.

  2006cites this paper
• Thermosensitive nanocontainers prepared from poly(N-isopropylacrylamide-co-N-(hydroxylmethyl) acrylamide)-g-poly(lactide).

  2006cites this paper
• Biodegradable microspheres for parenteral delivery.

  2005cites this paper
• Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.

  2005cites this paper
• Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.

  2005cites this paper
• In vitro and in vivo analysis of antide delivery from multi‐phase microspheres fabricated via solvent removal

  2005cites this paper
• Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation.

  2005cites this paper
• Drug release from cast films of ethylene vinyl acetate (EVA) copolymer: Stability of drugs by 1H NMR and solid state 13C CP/MAS NMR

  2005cites this paper
• Intraocular sustained drug delivery using implantable polymeric devices.

  2005cites this paper
• Preparation and evaluation of glycyrrhetic acid‐containing microparticles as an anti‐hepatotoxic system

  2005cites this paper
• PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases.

  2005cites this paper
• Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/ poly(α-ester) multiblock copolymer

  2004cites this paper
• Percutaneous Absorption Study of Biodegradable PLGA Nano-spheres via Human Skin Biopsies

  2004cites this paper
• Processing, annealing and sterilisation of poly-L-lactide.

  2004cites this paper
• Drug delivery systems for vitreoretinal diseases.

  2004cites this paper
• Glycyrrhetic acid‐loaded microparticles: liver‐specific delivery and therapeutic potential against carbon tetrachloride‐induced hepatitis

  2004cites this paper
• Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers

  2004cites this paper
• Development of implant tablet for a week-long sustained release.

  2004cites this paper
• Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/ poly(alpha-ester) multiblock copolymer.

  2004cites this paper
• Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.

  2004cites this paper
• Preparation of a copoly (dl-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone.

  2003cites this paper
• A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release.

  2003cites this paper
• Preparation and Characterization of Chitosan Microspheres Containing Doxifluridine

  2003cites this paper
• Microencapsulation of Protein Drugs: A Novel Approach

  2003cites this paper
• がん治療におけるDrug Delivery System

  2003cites this paper
• Effect of lecithin and MgCO3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly(lactide-co-glycolide) (PLGA) microspheres.

  2002cites this paper
• Biodegradation of Aliphatic Polyesters

  2002cites this paper
• Clinical Pharmacokinetics of Depot Leuprorelin

  2002cites this paper
• Microencapsulation methods for delivery of protein drugs

  2001cites this paper
• Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents.

  2001cites this paper
• Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing.

  2001cites this paper
• Scale-Up, Validation and Manufacturing of Microspheres

  2000cites this paper
• Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.

  2000cites this paper
• Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin

  2000cites this paper
• Bioconjugation of Biodegradable Poly (lactic/glycolic acid)to Protein,Peptide, and Anti-Cancer Drug: An Alternative

  2000cites this paper
• Site-Specific Administration of Antisense Oligonucleotides using Biodegradable Polymer Microspheres Provides Sustained Delivery and Improved Subcellular Biodistribution in the Neostriatum of the Rat Brain

  2000cites this paper
• Microspheres for Protein and Peptide Delivery: Applications and Opportunities

  2000cites this paper
• Porcine Insulin Biodegradable Polyester Microspheres: Stability and In Vitro Release Characteristics

  2000cites this paper
• Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.

  1999cites this paper
• Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.

  1999cites this paper
• Biodegradation and distribution of water-soluble chitosan in mice.

  1999cites this paper
• Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.

  1999cites this paper
• Antitumor effect of cisplatin incorporated into polylactic acid microcapsules.

  1999cites this paper
• Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.

  1999cites this paper
• Biocompatibility of Poly (DL-Lactide-co-Glycolide) Microspheres Implanted into the Brain

  1999cites this paper
• Biodegradable Microparticles for the Development of Less-Painful and Less-Irritating Parenterals

  1999cites this paper
• Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

  1998cites this paper
• Preparation and characterization of oil-in-water type poly (D,L-lactic acid) microspheres containing testosterone enanthate.

  1998cites this paper
• Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide).

  1998cites this paper
• A Large-Scale Process to Produce Microencapsulated Proteins

  1998cites this paper
• New strategies for the microencapsulation of tetanus vaccine.

  1998cites this paper
• Development and Scale‐up of a Microsphere Protein Delivery System

  1998cites this paper